ResMed Inc.

ResMed Inc.

RMDยทNYSE

$186.46

+2.0%
HealthcareMedical - Devices

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

At a Glance

Live Snapshot
Market Cap$27.05B
EPS9.5500
P/E Ratio19.52
Earnings Date07/30/2026
ResMed Inc.

ResMed Inc. Fair Value Envelope

RMD ยท NYSE

Our analysis suggests that RMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $186.46, this represents a potential HIDDEN relative to our calculated worth for ResMed Inc..

Intrinsic Value
Current Price: $186.46

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$229.4B
+ Cash & Equivalents$1.2B
Firm Value$230.6B
- Debt$851.8M
Equity Value$229.7B
/ Shares Outstanding146,547,729B
DCF Value$1.6K
UNDERVALUED BY 741%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$2.3B
$2.9B
$3.8B
$4.9B
$6.3B
$8.1B
$10.5B
$13.6B
$17.5B
$22.7B
Maintenance CapEx
-$23.2M
-$30.0M
-$38.7M
-$50.0M
-$64.6M
-$83.5M
-$107.9M
-$139.3M
-$180.0M
-$232.5M
Owner Earnings
$2.2B
$2.9B
$3.7B
$4.8B
$6.2B
$8.1B
$10.4B
$13.4B
$17.4B
$22.4B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$2.1B
$2.5B
$3.0B
$3.5B
$4.2B
$5.1B
$6.1B
$7.3B
$8.7B
$10.4B
Terminal Value represents 77.0% of Enterprise Value